Eisai

Eisai

World Rank (Jan-05-2024)
1,230
Market Cap (Jan-05-2024)
14.345 Billion USD
World Rank (Jul-30-2023)
995
Market Cap (Jul-30-2023)
18.227 Billion USD
World Rank (Jan-07-2022)
1,258
Market Cap (Jan-07-2022)
16.116 Billion USD
World Rank (Jan-01-2021)
897
Market Cap (Jan-01-2021)
20.290 Billion USD
Company Rank in Country in 2023
Rank in Japan in 2023 is 73
Headquarters Country
Japan
Market Cap (Mar-08-2026)
8.68
CEO
Haruo Naito
Employee Count
11,076
Employee Count as of Date
As on 2023
Headquarters City/State
Tokyo
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
5,273 Million USD
Annual Operating Income in USD
284 Million USD
Annual Net Income in USD
393 Million USD
Annual Results for Period Ending
Mar-2023 ending year
Total Assets in USD
8,950 Million USD
Total Liabilities in USD
3,122 Million USD
Total Equity in USD
5,827 Million USD
Balance Sheet for Period Ending
Mar-2023 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
EISAI CO.,LTD.
Wikipedia
Wikipedia
Yahoo
Yahoo @ Tokyo
Company Profile

Eisai is Pharmaceutical and Healthcare Products company with headquarters is in Tokyo, Japan.

Facts About Company

For year ending March-2023, Eisai annual revenue was 744 billion JPY, annual operating income was 40 billion JPY and annual net income was 55.4 billion JPY.

Eisai had 11,076 employees as on 2023.

It had 15 Drug Discovery, Research and Development, and Clinical Research Sites and 9 Production sites.

Founded Year
1941
Stock Category
NIKKEI 225
Stock Exchange
Tokyo

Share